financial results Enzo Biochem Q3 Revenues Nearly Double on Clinical Lab Testing Demand The recent quarter reflected growing demand for testing services and a steady improvement in sales of its products and services, the firm said. GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month. Agilent Q2 Revenues Rise 23 Percent The company's revenues rose to $1.53 billion from $1.24 billion and beat the analysts' average estimate of $1.40 billion. Burning Rock Q1 Revenues Rise 58 Percent The Guangzhou, China-based company said it tested 7,716 patients through its central lab during the quarter, driving its overall revenue growth. Genetron Health Q1 Revenues up 20 Percent Driven by LDT sales, especially of its early liver cancer screening assay, HCCscreen, the company's core oncology business grew 53 percent year over year. May 20, 2021 Olink Q1 Revenues Rise 70 Percent May 18, 2021 Akoya Biosciences Q1 Revenues Rise 11 Percent May 17, 2021 Oncocyte Posts $1.1M in Q1 Revenues, Beating Wall Street Expectations May 14, 2021 DiaSorin Q1 Revenues Rise 53 Percent on SARS-CoV-2 Testing Demand May 14, 2021 Co-Diagnostics Posts Q1 Revenue Boost on SARS-CoV-2 Test Sales May 13, 2021 Lucira Health Posts $4.5M in Sales in First Quarter as Publicly Traded Firm May 13, 2021 Bionano Genomics Q1 Revenues Almost Triple May 13, 2021 HTG Molecular Diagnostics Q1 Revenues Drop 36 Percent May 13, 2021 Progenity Q1 Revenues up 46 Percent May 13, 2021 OpGen Q1 Revenues Rise 34 Percent on Combination With Curetis May 12, 2021 Biocept Q1 Revenues Up Dramatically as COVID-19 Testing Boost Lingers May 12, 2021 Interpace Biosciences Q1 Revenues Up 8 Percent May 11, 2021 Biodesix Q1 Revenues Soar on COVID-19 Testing May 10, 2021 NanoString Technologies Q1 Revenues Grow 19 Percent May 10, 2021 Veracyte Q1 Revenues Up 18 Percent; CEO Transition Underway May 10, 2021 Castle Biosciences Q1 Revenues Up 31 Percent May 10, 2021 Seer Q1 Revenues Fall on Decline in Grant Revenue May 7, 2021 Fulgent Genetics Q1 Revenues Soar on SARS-CoV-2 Testing May 7, 2021 Meridian Bioscience Fiscal Q2 Revenues Up 49 Percent May 6, 2021 Quidel Q1 Revenues More Than Double but Miss Expectations Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.